Enanta Pharmaceuticals Inc (ENTA)
12.48
-0.44
(-3.41%)
USD |
NASDAQ |
Apr 25, 16:00
12.48
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Price to Book Value: 1.376 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 24, 2024 | 1.424 |
April 23, 2024 | 1.450 |
April 22, 2024 | 1.482 |
April 19, 2024 | 1.469 |
April 18, 2024 | 1.459 |
April 17, 2024 | 1.544 |
April 16, 2024 | 1.694 |
April 15, 2024 | 1.781 |
April 12, 2024 | 1.814 |
April 11, 2024 | 1.847 |
April 10, 2024 | 1.824 |
April 09, 2024 | 1.854 |
April 08, 2024 | 1.804 |
April 05, 2024 | 1.820 |
April 04, 2024 | 1.784 |
April 03, 2024 | 1.842 |
April 02, 2024 | 1.803 |
April 01, 2024 | 1.876 |
March 28, 2024 | 1.925 |
March 27, 2024 | 1.822 |
March 26, 2024 | 1.759 |
March 25, 2024 | 1.537 |
March 22, 2024 | 1.609 |
March 21, 2024 | 1.613 |
March 20, 2024 | 1.599 |
Date | Value |
---|---|
March 19, 2024 | 1.548 |
March 18, 2024 | 1.490 |
March 15, 2024 | 1.567 |
March 14, 2024 | 1.528 |
March 13, 2024 | 1.592 |
March 12, 2024 | 1.603 |
March 11, 2024 | 1.663 |
March 08, 2024 | 1.698 |
March 07, 2024 | 1.733 |
March 06, 2024 | 1.727 |
March 05, 2024 | 1.660 |
March 04, 2024 | 1.726 |
March 01, 2024 | 1.692 |
February 29, 2024 | 1.584 |
February 28, 2024 | 1.577 |
February 27, 2024 | 1.549 |
February 26, 2024 | 1.548 |
February 23, 2024 | 1.484 |
February 22, 2024 | 1.379 |
February 21, 2024 | 1.431 |
February 20, 2024 | 1.410 |
February 16, 2024 | 1.432 |
February 15, 2024 | 1.462 |
February 14, 2024 | 1.456 |
February 13, 2024 | 1.357 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7948
Minimum
Nov 13 2023
4.955
Maximum
Nov 05 2021
2.552
Average
2.346
Median
Apr 16 2021
Price to Book Value Benchmarks
Madrigal Pharmaceuticals Inc | 9.542 |
Galectin Therapeutics Inc | -- |
Viking Therapeutics Inc | 8.131 |
Akero Therapeutics Inc | 2.437 |
89bio Inc | 1.467 |
Price to Book Value Related Metrics
PS Ratio | 3.570 |
PEG Ratio | -0.1496 |
Price | 12.48 |
Earnings Yield | -52.56% |
Market Cap | 264.03M |
PEGY Ratio | -0.1496 |